GSK (GSK) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
22.9%

GSK earned a return on invested capital of 22.9% in fiscal 2025 (the year ended December 31, 2025). That is 5.4 percentage points higher than the 17.5% of fiscal 2024. Figures as of 17 Nov 2026, 23:35 UTC, from Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
22.9%
Change on fiscal 2024
+5.4 pts
Highest on record
24.6%fiscal 2022
Lowest on record
17.5%fiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

GSK return on invested capital (ROIC), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 24.6% in fiscal 2022 and the lowest 17.5% in fiscal 2024. The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 24.4%.

History · 4 fiscal years

Return on invested capital by fiscal year

GSK return on invested capital (ROIC), year by year

GSK (GSK) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
202522.9% 5.4 pts up
202417.5% 6.9 pts down
202324.4% 0.2 pts down
202224.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of GSK and comparable companies
CompanyReturn on invested capitalFiscal year
Sanofi SNY9.6%2025
Moderna MRNA-58.4%2025
CVS Health CVS5.8%2025
HCA Healthcare HCA22.7%2025
GSK GSK22.9%2025
Regeneron Pharmaceuticals REGN12.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GSK

GSK, figure by figure

GSK (GSK) overview: price, valuation and scorecardAll health care companies by market value

GSK return on invested capital (ROIC): questions and answers

What is GSK's return on invested capital?

GSK earned a return on invested capital of 22.9% in fiscal 2025 (the year ended December 31, 2025). That is 5.4 percentage points higher than the 17.5% of fiscal 2024.

Is GSK's return on invested capital high or low compared with its own history?

The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 24.4%.

What are the highest and lowest return on invested capital figures on record for GSK?

Across the 4 fiscal years on record (2022–2025), the highest was 24.6% in fiscal 2022 and the lowest 17.5% in fiscal 2024.

How is GSK's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “GSK (GSK) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/GSK/roic

Underlying data: Yahoo Finance.